Hepatitis C vaccine could dramatically reduce transmission in people who inject drugs
Among the most serious consequences of the opioid epidemic is the spread of hepatitis C among injecting drug users.
Jul 11, 2018
0
57
Among the most serious consequences of the opioid epidemic is the spread of hepatitis C among injecting drug users.
Jul 11, 2018
0
57
Researchers at University of California San Diego School of Medicine discovered that they can block inflammation in mice with a naturally occurring antibody that binds oxidized phospholipids (OxPL), molecules on cell surfaces ...
Jun 6, 2018
1
612
Scientists at Imperial College London have become the first in the world to test how pathogens interact with artificial human organs.
Feb 14, 2018
0
53
Indiana University researchers have made an important step forward in the design of drugs that fight the hepatitis B virus, which can cause liver failure and liver cancer.
Feb 6, 2018
0
44
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...
Jul 19, 2017
0
33
A major new insight into how Hepatitis B Virus works could pave the way for new drug treatments for the infection which is the major cause of liver cancer worldwide.
Jun 19, 2017
0
49
A big data study of hepatitis C and more than 500 patients with the virus has opened the way for a better understanding of how the virus interacts with its human hosts.
Apr 11, 2017
0
69
A combination of two cancer drugs inhibited both dengue and Ebola virus infections in mice in a study led by Stanford University School of Medicine researchers, despite the fact that these two viruses are vastly different ...
Feb 27, 2017
0
54
The technique that the hepatitis E virus—an emerging liver virus historically found in developing countries but now on the rise in Europe—uses to spread could present a weak spot scientists can exploit to treat the disease, ...
Jan 17, 2017
0
44
The virus that causes hepatitis C protects itself by blocking signals that call up immune defenses in liver cells, according to University of Washington researchers and colleagues reporting Nov. 14 in Nature Medicine.
Nov 17, 2016
0
40